Our mission is to develop disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases to address the unmet medical need.
-
Highlight
Minutes of Herantis Pharma Plc’s Annual General Meeting of shareholders April 24, 2024.
-
Highlight
Watch Herantis Pharma’s Full Year 2023 webcast here